Clinical improvement (Rachmilewitz index) (14 days) · people with mild‐to‐moderate disease (Rachmilewitz index) or active disease (SCCAI score of 4 to 10)
1 finding from 1 review
Health‐related quality of life (timeframe not reported) ‐ IBDQ ‐ Symptoms‐guided diet · people with mild‐to‐moderate disease (Rachmilewitz index) or active disease (SCCAI score of 4 to 10)
1 finding from 1 review
no estimate extracted
1 study · 8 participants
Very low
Total adverse events · people with mild‐to‐moderate disease (Rachmilewitz index) or active disease (SCCAI score of 4 to 10)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with mild‐to‐moderate disease (Rachmilewitz index) or active disease (SCCAI score of 4 to 10)
It is very uncertain whether prebiotics changes withdrawals due to adverse events (14 days to 2 or 3 months) compared with placebo (very low certainty).
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
Antibiotics showed no clear difference in failure to induce clinical remission at end of study compared with placebo (high certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
It is very uncertain whether antibiotics changes failure to induce clinical response at end of study compared with 5‐ASA (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
It is very uncertain whether antibiotics changes failure to induce clinical remission at end of study compared with probiotics (very low certainty).
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
1 finding from 1 review
Failure to maintain clinical remission at end of study · Patients with quiescent ulcerative colitis
It is very uncertain whether antibiotics changes failure to maintain clinical remission at end of study compared with 5‐ASA (very low certainty).
1 finding from 1 review
Failure to maintain clinical response · Patients with quiescent ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · Patients with quiescent ulcerative colitis
1 finding from 1 review
Failure to induce clinical response at end of study · people with active UC
Antibiotics showed no clear difference in failure to induce clinical response at end of study compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with quiescent ulcerative colitis
1 finding from 1 review
Serious adverse events · people with active UC
Antibiotics showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
Antibiotics showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Failure to induce clinical remission at end of study · people with active UC
It is very uncertain whether antibiotics plus probiotics changes failure to induce clinical remission at end of study compared with placebo or no intervention (very low certainty).
1 finding from 1 review